IBDEI2CG ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39367,0)
 ;;=I69.954^^183^2019^12
 ;;^UTILITY(U,$J,358.3,39367,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39367,1,3,0)
 ;;=3^Hemiplga fol unsp cerebvasc disease aff left nondom side
 ;;^UTILITY(U,$J,358.3,39367,1,4,0)
 ;;=4^I69.954
 ;;^UTILITY(U,$J,358.3,39367,2)
 ;;=^5133587
 ;;^UTILITY(U,$J,358.3,39368,0)
 ;;=I69.951^^183^2019^13
 ;;^UTILITY(U,$J,358.3,39368,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39368,1,3,0)
 ;;=3^Hemiplga fol unsp cerebvasc disease aff right dominant side
 ;;^UTILITY(U,$J,358.3,39368,1,4,0)
 ;;=4^I69.951
 ;;^UTILITY(U,$J,358.3,39368,2)
 ;;=^5007561
 ;;^UTILITY(U,$J,358.3,39369,0)
 ;;=I69.953^^183^2019^14
 ;;^UTILITY(U,$J,358.3,39369,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39369,1,3,0)
 ;;=3^Hemiplga fol unsp cerebvasc disease aff right nondom side
 ;;^UTILITY(U,$J,358.3,39369,1,4,0)
 ;;=4^I69.953
 ;;^UTILITY(U,$J,358.3,39369,2)
 ;;=^5007562
 ;;^UTILITY(U,$J,358.3,39370,0)
 ;;=G81.92^^183^2019^7
 ;;^UTILITY(U,$J,358.3,39370,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39370,1,3,0)
 ;;=3^Hemiplegia, unspecified affecting left dominant side
 ;;^UTILITY(U,$J,358.3,39370,1,4,0)
 ;;=4^G81.92
 ;;^UTILITY(U,$J,358.3,39370,2)
 ;;=^5004122
 ;;^UTILITY(U,$J,358.3,39371,0)
 ;;=G81.94^^183^2019^8
 ;;^UTILITY(U,$J,358.3,39371,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39371,1,3,0)
 ;;=3^Hemiplegia, unspecified affecting left nondominant side
 ;;^UTILITY(U,$J,358.3,39371,1,4,0)
 ;;=4^G81.94
 ;;^UTILITY(U,$J,358.3,39371,2)
 ;;=^5004124
 ;;^UTILITY(U,$J,358.3,39372,0)
 ;;=G81.91^^183^2019^9
 ;;^UTILITY(U,$J,358.3,39372,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39372,1,3,0)
 ;;=3^Hemiplegia, unspecified affecting right dominant side
 ;;^UTILITY(U,$J,358.3,39372,1,4,0)
 ;;=4^G81.91
 ;;^UTILITY(U,$J,358.3,39372,2)
 ;;=^5004121
 ;;^UTILITY(U,$J,358.3,39373,0)
 ;;=G81.93^^183^2019^10
 ;;^UTILITY(U,$J,358.3,39373,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39373,1,3,0)
 ;;=3^Hemiplegia, unspecified affecting right nondominant side
 ;;^UTILITY(U,$J,358.3,39373,1,4,0)
 ;;=4^G81.93
 ;;^UTILITY(U,$J,358.3,39373,2)
 ;;=^5004123
 ;;^UTILITY(U,$J,358.3,39374,0)
 ;;=I69.942^^183^2019^23
 ;;^UTILITY(U,$J,358.3,39374,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39374,1,3,0)
 ;;=3^Monoplg low lmb fol unsp cerebvasc dis aff left dom side
 ;;^UTILITY(U,$J,358.3,39374,1,4,0)
 ;;=4^I69.942
 ;;^UTILITY(U,$J,358.3,39374,2)
 ;;=^5133582
 ;;^UTILITY(U,$J,358.3,39375,0)
 ;;=I69.944^^183^2019^24
 ;;^UTILITY(U,$J,358.3,39375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39375,1,3,0)
 ;;=3^Monoplg low lmb fol unsp cerebvasc dis aff left nondom side
 ;;^UTILITY(U,$J,358.3,39375,1,4,0)
 ;;=4^I69.944
 ;;^UTILITY(U,$J,358.3,39375,2)
 ;;=^5133585
 ;;^UTILITY(U,$J,358.3,39376,0)
 ;;=I69.941^^183^2019^25
 ;;^UTILITY(U,$J,358.3,39376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39376,1,3,0)
 ;;=3^Monoplg low lmb fol unsp cerebvasc dis aff right dom side
 ;;^UTILITY(U,$J,358.3,39376,1,4,0)
 ;;=4^I69.941
 ;;^UTILITY(U,$J,358.3,39376,2)
 ;;=^5133581
 ;;^UTILITY(U,$J,358.3,39377,0)
 ;;=I69.943^^183^2019^26
 ;;^UTILITY(U,$J,358.3,39377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39377,1,3,0)
 ;;=3^Monoplg low lmb fol unsp cerebvasc dis aff right nondom side
 ;;^UTILITY(U,$J,358.3,39377,1,4,0)
 ;;=4^I69.943
 ;;^UTILITY(U,$J,358.3,39377,2)
 ;;=^5133584
 ;;^UTILITY(U,$J,358.3,39378,0)
 ;;=G35.^^183^2019^27
 ;;^UTILITY(U,$J,358.3,39378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39378,1,3,0)
 ;;=3^Multiple sclerosis
 ;;^UTILITY(U,$J,358.3,39378,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,39378,2)
 ;;=^79761
